NO157864C - Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater. - Google Patents
Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater.Info
- Publication number
- NO157864C NO157864C NO832738A NO832738A NO157864C NO 157864 C NO157864 C NO 157864C NO 832738 A NO832738 A NO 832738A NO 832738 A NO832738 A NO 832738A NO 157864 C NO157864 C NO 157864C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- dichlorated
- 16alfa
- therapeutically effective
- derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C31/13—Monohydroxylic alcohols containing saturated rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C68/00—Preparation of esters of carbonic or haloformic acids
- C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
- C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
- C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Rheumatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8216668A FR2533928A1 (fr) | 1982-10-05 | 1982-10-05 | Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO832738L NO832738L (no) | 1984-04-06 |
| NO157864B NO157864B (no) | 1988-02-22 |
| NO157864C true NO157864C (no) | 1988-06-01 |
Family
ID=9277977
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO832738A NO157864C (no) | 1982-10-05 | 1983-07-27 | Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4515787A (zh) |
| JP (1) | JPS59116300A (zh) |
| AT (1) | AT385996B (zh) |
| AU (1) | AU563739B2 (zh) |
| BE (1) | BE897906A (zh) |
| CA (1) | CA1203234A (zh) |
| CH (1) | CH659251A5 (zh) |
| DE (1) | DE3336292A1 (zh) |
| DK (1) | DK164062C (zh) |
| ES (1) | ES526212A0 (zh) |
| FI (1) | FI77668C (zh) |
| FR (1) | FR2533928A1 (zh) |
| GB (1) | GB2127827B (zh) |
| HU (1) | HU190506B (zh) |
| IE (1) | IE56022B1 (zh) |
| IT (1) | IT1197713B (zh) |
| MA (1) | MA19909A1 (zh) |
| NL (1) | NL8303409A (zh) |
| NO (1) | NO157864C (zh) |
| OA (1) | OA07558A (zh) |
| SE (1) | SE447388B (zh) |
| ZA (1) | ZA836538B (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2561919B1 (fr) * | 1984-04-03 | 1986-12-19 | Roussel Uclaf | Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon |
| GB8512738D0 (en) * | 1984-09-04 | 1985-06-26 | Gen Electric | Silylation method |
| ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
| US7247607B2 (en) * | 2001-11-08 | 2007-07-24 | Green & Clean, Inc. | Active soluble cleaning composite of natural state using soybean fatty acids and the making method thereof |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2342738A1 (fr) * | 1976-03-02 | 1977-09-30 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16a-methyl pregnane |
| FR2381065A2 (fr) * | 1977-02-22 | 1978-09-15 | Roussel Uclaf | Nouveaux derives halogenes de la serie du 16 a-methyl pregnane |
| FR2462443A1 (fr) * | 1979-07-26 | 1981-02-13 | Roussel Uclaf | Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament |
-
1982
- 1982-10-05 FR FR8216668A patent/FR2533928A1/fr active Granted
-
1983
- 1983-07-20 SE SE8304062A patent/SE447388B/sv not_active IP Right Cessation
- 1983-07-27 NO NO832738A patent/NO157864C/no unknown
- 1983-09-03 ZA ZA836538A patent/ZA836538B/xx unknown
- 1983-09-15 US US06/532,739 patent/US4515787A/en not_active Expired - Fee Related
- 1983-09-19 IT IT48990/83A patent/IT1197713B/it active
- 1983-09-28 MA MA20132A patent/MA19909A1/fr unknown
- 1983-09-30 AU AU19824/83A patent/AU563739B2/en not_active Ceased
- 1983-10-04 DK DK456483A patent/DK164062C/da not_active IP Right Cessation
- 1983-10-04 CH CH5395/83A patent/CH659251A5/fr not_active IP Right Cessation
- 1983-10-04 FI FI833602A patent/FI77668C/fi not_active IP Right Cessation
- 1983-10-04 ES ES526212A patent/ES526212A0/es active Granted
- 1983-10-04 CA CA000438264A patent/CA1203234A/fr not_active Expired
- 1983-10-04 BE BE0/211641A patent/BE897906A/fr not_active IP Right Cessation
- 1983-10-04 IE IE2337/83A patent/IE56022B1/en not_active IP Right Cessation
- 1983-10-04 HU HU833444A patent/HU190506B/hu not_active IP Right Cessation
- 1983-10-04 GB GB08326527A patent/GB2127827B/en not_active Expired
- 1983-10-05 NL NL8303409A patent/NL8303409A/nl not_active Application Discontinuation
- 1983-10-05 OA OA58129A patent/OA07558A/xx unknown
- 1983-10-05 JP JP58185211A patent/JPS59116300A/ja active Granted
- 1983-10-05 DE DE19833336292 patent/DE3336292A1/de active Granted
- 1983-10-05 AT AT0352783A patent/AT385996B/de not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO158461C (no) | Analogifremgangsmaate for fremstilling av fenyl-piperidin-propanol-derivater. | |
| NO159531C (no) | Analogifremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater. | |
| NO158099C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO163691C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider. | |
| NO161372C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater. | |
| NO153177C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater. | |
| NO154919C (no) | Analogifremgangsmaate ved fremstilling av nye kinazolinderivater. | |
| NO151085C (no) | Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater | |
| NO156864C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater. | |
| NO164835C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| NO159446C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater. | |
| NO152129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater | |
| NO891191D0 (no) | Fremgangsmaate for fremstilling av nye, terapeutisk virksomme catecholderivater. | |
| NO160444C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner. | |
| NO159654C (no) | Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater. | |
| NO161676C (no) | Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater. | |
| NO159930C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater. | |
| NO160074C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk aktive kinolinonderivater. | |
| NO160079C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater. | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO158739C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater. | |
| NO160511C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater. | |
| NO157864C (no) | Analogifremgangsaate for fremstilling av nye, terapeutisk virksomme diklorerte 16alfa-methylpregnanderivater. | |
| NO158743C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive mitosanforbindelser. | |
| NO156865C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater. |